Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 17, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 17, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record85720 flagged findings
Reported transactions (Form 4)80since Jan 20, 2023 · and 5 other holdings
Corporate events (8-K)30since Sep 12, 2023
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-11share offering or dilution eventrecentOpen filing ↗“…the three months ended March 31, 2026 and 2025. As of March 31, 2026, the Company had approximately $ 64.9 million of its common…”
+1 more passage from the same document
- “…and 2025. As of March 31, 2026, the Company had approximately $ 64.9 million of its common stock remaining available for sales under…”
- 2026-05-11capital return (buybacks/dividends)recentOpen filing ↗“…principal amount of its 1.5 % Convertible Senior Subordinated Notes due 2026 (the “2026 Convertible Notes”). The 2026…”
+1 more passage from the same document
- “…% per annum, payable semi-annually in arrears on April 15 and October 15 of each year and matured on April 15, 2026 . On April 15,…”
- 2026-05-11regulatory investigationrecentOpen filing ↗“…withdraw regulatory approval; ● suspend any of our ongoing clinical studies; ● refuse to approve pending applications or supplements…”
- 2026-03-09share offering or dilution eventrecentOpen filing ↗“…this disclosure item is not applicable. Recent Sales of Unregistered Equity Securities On October 20, 2025, the Company entered…”
+1 more passage from the same document
- “…Recent Sales of Unregistered Equity Securities On October 20, 2025, the Company entered into a securities purchase agreement…”
- 2026-03-09capital return (buybacks/dividends)recentOpen filing ↗“…was in full compliance with these covenants, and there were no events of default under the 2026 Convertible Notes. On April 15,…”
+1 more passage from the same document
- “…On May 15, 2025, pursuant to the Fundamental Change Repurchase Right (as defined in the indenture, dated as of April 17, 2020…”
- 2026-03-09regulatory investigationrecentOpen filing ↗“…withdraw regulatory approval; ● suspend any of our ongoing clinical studies; ● refuse to approve pending applications or supplements…”
- 2026-03-09merger or acquisition eventrecentOpen filing ↗“…to Exhibits immediately preceding the signature page of this Annual Report on Form 10-K. Item 16. Form 10-K Summary None. 116…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 857)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 28, 268-K ↗Current report · Other events
- Aug 28, 26424B5 ↗Securities offering
- Aug 28, 26424B3 ↗Securities offering
- Aug 17, 268-K ↗Current report · Communication to the market · Other events
- Aug 17, 268-K ↗Current report · Took on a new financial obligation
- Aug 5, 2610-Q ↗Quarterly report
- Aug 5, 268-K ↗Current report · Results
- Jul 27, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.8% · event on Jun 30, 26
- Jun 15, 268-K ↗Current report · Auditor change filing (8-K Item 4.01)
Insider transaction · 9 Form 4 filingsshow all 9hide
- Jun 9, 26Form 4 ↗Insider transaction
- Jun 9, 26Form 4 ↗Insider transaction
- Jun 9, 26Form 4 ↗Insider transaction
- Jun 9, 26Form 4 ↗Insider transaction
- Jun 9, 26Form 4 ↗Insider transaction
- Jun 9, 26Form 4 ↗Insider transaction
- Jun 9, 26Form 4 ↗Insider transaction
- Jun 2, 26Form 4 ↗Insider transaction
- Jun 2, 26Form 4 ↗Insider transaction
- Jun 1, 268-K ↗Current report · Shareholder vote results
- May 28, 26DEFA14A ↗Shareholder meeting and votes
- May 15, 26SCHEDULE 13G/A ↗Passive stake · Timothy G. Youngquist 2020 Irrevocable Trust · 8.3% · event on Mar 31, 26 · amendment
- May 11, 26SCHEDULE 13G/A ↗Passive stake · amendment
- May 11, 2610-Q ↗Quarterly report
- May 11, 268-K ↗Current report · Results
- May 5, 26DEFA14A ↗Shareholder meeting and votes
857 filings on record, the oldest from Sep 3, 14.
Listing the 25 most recent filings of the 857 on record.
46529
- Aug 17, 26Took on a new financial obligation+3 more in the same filing8-K 2.03 ↗
- Jun 15, 26Auditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
- Jul 3, 25Listing notice (8-K 3.01)8-K 3.01 ↗
- Apr 25, 25A senior executive left or was appointed8-K 5.02 ↗
- Apr 22, 25A senior executive left or was appointed8-K 5.02 ↗
- Apr 14, 25Completed an acquisition or disposal+2 more in the same filing8-K 2.01 ↗
- Apr 1, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Dec 4, 24A senior executive left or was appointed8-K 5.02 ↗
- Dec 3, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Aug 8, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 2, 24Entered a material agreement8-K 1.01 ↗
- Jun 27, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
11 older filings not shown · The record reaches back to Dec 11, 14.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Mar 4, 24A debt obligation was accelerated+3 more in the same filing8-K 2.04 ↗
- Mar 6, 23Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Jun 27, 17Restructuring plan with committed costs8-K 2.05 ↗
The full record holds 4 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Timothy G. Youngquist 2020 Irrevocable Trust8.3%Mar 31, 26SCHEDULE 13G/A ↗1 earlier filing
- The Vanguard Group8.3%Dec 31, 25SCHEDULE 13G/A ↗
- Evgeny Zaytsev ("Zaytsev")6.5%Sep 5, 25SCHEDULE 13G ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
- BlackRock, Inc.5.8%Jun 30, 26SCHEDULE 13G ↗3 earlier filings
- Thomas A. Satterfield, Jr.4.6%Mar 31, 26SCHEDULE 13G/A ↗1 earlier filing
show one more holderhide
- Rubric Capital Management LP4.6%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Stock compensation, tax and giftsshow the 38 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jun 5, 26Compensationamount n/aCharles W. Newton↗
- Jun 5, 26Compensationamount n/aMats Wahlstrom↗
- Jun 5, 26Compensationamount n/aJill O'Donnell-Tormey↗
- Jun 5, 26Compensationamount n/aMichael Lee Ryan↗
- Jun 5, 26Compensationamount n/aLee Nisley Newcomer↗
- Jun 5, 26Compensationamount n/aRita A Karachun↗
- Jun 5, 26Compensationamount n/aAli J. Satvat↗
- Jan 23, 26Compensationamount n/aDennis M LanfearPresident & CEO↗
- Jan 22, 26Compensationamount n/aBryan J McMichaelChief Financial Officer↗
- Jan 20, 26Tax$18KDennis M LanfearPresident & CEO↗
- Jan 20, 26Tax$3KBryan J McMichaelChief Financial Officer↗
- Jan 20, 25Tax$16KDennis M LanfearPresident & CEO↗
- Jan 20, 25Tax$7KPaul ReiderChief Commercial Officer↗
- Jan 20, 25Tax$2KBryan J McMichaelChief Financial Officer↗
- Jan 7, 25Tax$3KBryan J McMichaelChief Financial Officer↗
- Jan 4, 25Tax$4KPaul ReiderChief Commercial Officer↗
- Jan 4, 25Tax$20KDennis M LanfearPresident & CEO↗
- Dec 13, 24Tax$3KPaul ReiderChief Commercial Officer↗
- Feb 9, 24Giftamount n/aMats Wahlstrom↗
- Feb 9, 24Giftamount n/aMats Wahlstrom↗
- Feb 1, 24Compensation$25KMats Wahlstrom↗
- Feb 1, 24Compensation$75KMats Wahlstrom↗
- Jan 20, 24Tax$4KBryan J McMichaelSee Remarks↗
- Jan 20, 24Tax$12KPaul ReiderChief Commercial Officer↗
- Jan 20, 24Tax$27KDennis M LanfearPresident & CEO↗
- Jan 7, 24Tax$5KBryan J McMichaelSee Remarks↗
- Jan 4, 24Tax$7KPaul ReiderChief Commercial Officer↗
- Jan 4, 24Tax$34KDennis M LanfearPresident & CEO↗
- Dec 31, 23Tax$61KMcDavid StilwellChief Financial Officer↗
- Dec 13, 23Tax$5KPaul ReiderChief Commercial Officer↗
- Nov 22, 23Compensation$58KDennis M LanfearPresident & CEO↗
- Nov 22, 23Compensation$367KDennis M LanfearPresident & CEO↗
- Apr 1, 23Tax$24KMcDavid StilwellChief Financial Officer↗
- Apr 1, 23Tax$17KPaul ReiderChief Commercial Officer↗
- Mar 31, 23Tax$111KVladimir VexlerChief Scientific Officer↗
- Jan 20, 23Compensationamount n/aMcDavid StilwellChief Financial Officer↗
- Jan 20, 23Compensationamount n/aVladimir VexlerChief Scientific Officer↗
- Jan 20, 23Compensationamount n/aBryan J McMichaelSee Remarks↗
The full record holds 48 transactions and goes back to Dec 30, 22.
Its sector and its market
Coherus Oncology, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Coherus Oncology, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Coherus Oncology, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 857 documents on file, from Sep 3, 2014 to Aug 28, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.